Israel-based developer of the XACT ACE robotic system for percutaneous procedures such as biopsies and ablations.
Founded in 2013 in Israel, XACT Robotics Ltd. develops and sells robotic systems for percutaneous procedures. Its XACT ACE Robotic System, built on S-Drive technology, supports biopsies, ablations and therapeutic drug delivery, and its customers are hospitals and medical facilities in North America, Europe and Asia. The company has raised USD 36.00 mn in total, with its latest Series D round in November 2019 led by Chasing Value Asset Management, Inc. It has completed 4 deals to date.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in